Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
33.9M
-
Number of holders
-
380
-
Total 13F shares, excl. options
-
37.1M
-
Shares change
-
+824K
-
Total reported value, excl. options
-
$4.16B
-
Value change
-
+$59.4M
-
Put/Call ratio
-
0.91
-
Number of buys
-
218
-
Number of sells
-
-169
-
Price
-
$112.20
Significant Holders of TransMedics Group, Inc. - Common Stock (TMDX) as of Q3 2025
463 filings reported holding TMDX - TransMedics Group, Inc. - Common Stock as of Q3 2025.
TransMedics Group, Inc. - Common Stock (TMDX) has 380 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 37.1M shares
.
Largest 10 shareholders include BlackRock, Inc. (5.33M shares), FMR LLC (5.06M shares), VANGUARD GROUP INC (3.61M shares), STATE STREET CORP (1.28M shares), UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC (1.07M shares), MACQUARIE GROUP LTD (906K shares), UBS Group AG (856K shares), GEODE CAPITAL MANAGEMENT, LLC (814K shares), Driehaus Capital Management LLC (738K shares), and GOLDMAN SACHS GROUP INC (704K shares).
This table shows the top 380 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.